Preview

case study -ALLEGEX NASAL SPRAY

Satisfactory Essays
Open Document
Open Document
717 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
case study -ALLEGEX NASAL SPRAY
Case Study
ALLEGEX NASAL SPRAY

Agenda
Introduction
Analysis
Alternatives
- Working Overtime - Adding an Operator - New Automated System - Overtime and Adding Operator Recommendation Conclusion

Introduction
Problem:
In Cambridge we can only produce 15,000 units of Allegex per week
We cannot meet the demand of 19,000 bottles per week
Is there a way Cambridge can meet this demand?
Purpose:
Find an option that would be best suited for Pharma to meet current and future demand.
Scope:
To discuss our options that we were given to aid in our 19,000 units endeavour.
Overtime shifts on weekends
Adding an additional operator to the line
Automating all of the packaging operations
Combine adding an operator and overtime

Analysis
Resources : Current Demand= 19,000 units/week Cambridge Facility Capacity= 15,000 units/week
People:
4 employees per shift, 3 shifts per day, 5 days per week.
Processes:
The extra 4,000 is produced in a facility in the Unites States but the changeovers are costly and inefficient. This results in a contribution of $3 less per bottle than the Cambridge plant.

Constraints:
The future demand could increase to 23,000 units per week within 2 years Allegex’s patent protection expires in 2003 which opens the door to generic imitations.

Overtime Shifts
Adding an Operator
New Automated System
Overtime and Adding Operator
Current Demand
19,000 units
19,000 units
19,000 units
19,000 units
Current Capacity
15,000 units
15,000 units
15,000 units
15,000 units
Possible Future Demand
23,000 units
23,000 units
23,000 units
23,0000 units
New Capacity
19,000 units
18,750 units
24,000 units
22,750 units
Meet Current Demand
Yes
No
Yes
Yes
Meet Future Demand
No
No
Yes
Almost
Current Labour Cost
$7,200
$7,200
$7,200
$7,200
New Labour Cost
$10,080
$9,000
$2,040
$11,880
Labour Savings
($2,880)
($1,800)

You May Also Find These Documents Helpful

  • Powerful Essays

    Audit Case ch 6

    • 1999 Words
    • 13 Pages

    To discuss when planning meetings for the audit of the current year-end will take place.…

    • 1999 Words
    • 13 Pages
    Powerful Essays
  • Powerful Essays

    The Medicines Company

    • 868 Words
    • 5 Pages

    Medicines Company’s drug, Angiomax, outperforms heparinHeparin, but requireincurs a significantly higher price costs to produce. This , makesing the drug difficult to attractively price towards hospitals. This difficulty in pricing stems from a poor positioning strategy for Angiomax which does not maximize the perceived value (PV) that the drug provides to its key customer segments. Therefore, Medicines Co., must develop a positioning strategy that maximizes the perceived value of Angiomax to a key customer segment.…

    • 868 Words
    • 5 Pages
    Powerful Essays
  • Satisfactory Essays

    Issues to Ponder: What would the preferred way to move these medical products from producer to consumer…

    • 353 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Brothers, know you should have all the information, requested to make your decison on what we will do going forward. Later this week, Bro. Wilson will send out a final agenda.…

    • 119 Words
    • 1 Page
    Satisfactory Essays
  • Satisfactory Essays

    Langreth, R. (2014, May). Big pharma 's favorite prescription: higher prices. , (), . Retrieved from…

    • 575 Words
    • 3 Pages
    Satisfactory Essays
  • Best Essays

    Rogers' Chocolates in 2007

    • 4152 Words
    • 17 Pages

    Jones, Paul, and Nic Holladay. "Getting the mix right, Part 1: roadblocks and routes to market; In the first of two articles, Paul Jones and Nic Holladay examine the context in which pharma is currently operating: how new market conditions are emerging; how the industry is responding; and why many companies have been slow to exploit the internet." Pharmaceutical Technology Europe 18.9 (2006): 51+. General OneFile. Web. 19 Oct. 2010.…

    • 4152 Words
    • 17 Pages
    Best Essays
  • Satisfactory Essays

    Questions 6

    • 535 Words
    • 2 Pages

    Underutilization of new effective drugs is a serious concern for pharmaceutical companies. There are many restrictions on pharmaceuticals companies to make their drug available for everyone. Certain restrictions like Medicaid will only allow specific medicine to be reimbursable. If a…

    • 535 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Emily was compliant with taking her routine medications, however she often declined her PRN allergy medication (Allegra Allergy 180 MG tab) when offered in instances that she was exhibiting and complaining of seasonal allergy symptoms. The large size of the pill may be contributing to her reluctance to take it. Staff contacted Emily's PCP (Dr. Tucker) and is in the process of having another PRN allergy medication authorized that is smaller and easier to swallow.…

    • 148 Words
    • 1 Page
    Good Essays
  • Satisfactory Essays

    Otc Pros And Cons

    • 459 Words
    • 2 Pages

    Option 01: Argue with FDA on the case for the treatment and prevention claims and there by preserve the opportunity to be the first entrant.…

    • 459 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Health Care Reform

    • 444 Words
    • 2 Pages

    Pharmaceutical companies will be able to offer more innovative products to a displaced population that has been previously underserved.…

    • 444 Words
    • 2 Pages
    Good Essays
  • Good Essays

    State briefly and specifically whether the decision to a) proceed with the drug project or b) not to proceed with the drug development best fits with the company's…

    • 639 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    The health care industry Provides health products and service which involved the leading technology of life science. It is a fast-growing industry and will continue to grow in the future because of the increasing request to the advanced medical care. The Global Industry Analysis (GIA,2009) predicted that the prescription drug market is value around $897 billion in world economy in 2015, and Asia-Pacific region is expected to have highest growth in prescription drugs.…

    • 1121 Words
    • 5 Pages
    Powerful Essays
  • Good Essays

    Merck Case

    • 587 Words
    • 4 Pages

    Merck had a 14% increase in sales between 1997 and 1998 and 22% increase in sales from 1998 – 1999, and a 13% annual increase in earnings over the same period. Merck’s business strategy consists of two parts: (1) developing and marketing new drugs through internal research, and (2) developing partnerships with smaller biotechnology companies. Since 1995, Merck had launched 15 new products that earned $5.9 billion on sales of $32.7 billion. Furthermore, Merck may agree to license new drugs from other firms and with its larger capital and greater assets, can assume the risk of submitting the drug through various regulatory approval phases. If the drug becomes profitable, Merck can earn significant cash flows while paying a royalty to the licensor. However, most important is the option that Merck has in deciding when to abandon or continue on this project (deferability or optionality). If Merck reaches a point when its expected NPV is negative, it can simply abandon the project. As a licensee, Merck can allow smaller biotechnology firms to focus on research and development. These smaller firms often have smaller budgets and are not financially or personnel equipped to handle the costly and long FDA approval process, and the subsequent marketing, distribution, and sales of new drugs. This task is better suited for a larger company, such as Merck, which has more resources and money.…

    • 587 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    Biopharma Case Study

    • 1265 Words
    • 6 Pages

    As of 2009, BioPharma is looking to reduce costs across the board. Profits have been steeply declining while production costs are high, especially at its German and Japanese facilities. With exception of India, demand is expected to remain relatively stable for the short-term future, so BioPharma can no longer afford its costly surplus capacity. BioPharma produces and sells two chemicals in bulk. Each plant they currently have is capable of producing both chemicals. They are willing to idle production at the Germany and Japan plants on one or both chemicals in order to reduce costs. They are also willing to reallocate which plant makes how much of each chemical and where they are distributed to.…

    • 1265 Words
    • 6 Pages
    Powerful Essays
  • Powerful Essays

    atlas honda

    • 1666 Words
    • 15 Pages

    By Ahmad Raza Asad Shoaib Awais Musawar Hamza Sahi Usman Rashid 1 Industry Analysis • Motorcycle Industry estimates show that last year a total of over 750000 motorcycles were sold in the country • The industry has been experiencing a healthy growth rate of around 30% per year for the past 4-5 years. • Pakistan came at number seven with a production of 750,000 units of motorcycles constituting to 2% of the global total. 2 Market Share of Motorbike in Pakistan 3 Company Profile • Atlas Honda Limited is a joint venture between the Atlas Group and Honda Motor Co Japan. •…

    • 1666 Words
    • 15 Pages
    Powerful Essays